Mergers & AcquisitionsMedium•18 November 2026•
1 min read
Impact BioMedical Completes Merger with Zoar Limited, Debuts New Ticker
Key Facts
1Impact BioMedical announced the completion of its merger with Zoar Limited.
2The merged entity's shares have commenced trading under a new ticker symbol on the NYSE American.
Impact BioMedical announced the completion of its merger with Zoar Limited. Investing.com reported that the merged entity's shares have commenced trading under a new ticker symbol on the NYSE American, following the finalization of the deal to combine the operations of both companies.
IBO closed at $6.17 on November 17, 2026, after reaching a day high of $6.45 and a low of $5.13 during the session. This corporate milestone coincides with broader economic data, as U.S. Retail Sales showed a 6.8% year-over-year increase on November 17, 2026.